IHL-675A Archives | Cannabiz

Incannex receives ethics approval for phase one clinical trial of CBD-based anti-inflammatory drug

by Martin Lane July 22, 2022August 16, 2023

Incannex Healthcare has received ethics approval for a phase one clinical trial of its cannabinoid-based anti-inflammatory […]

Company news: Cannasouth; MGC Pharmaceuticals; Creso Pharma; Incannex; Medlab

by Martin Lane July 19, 2021July 21, 2021

Incannex to develop single ‘lung inflammation program’

by Martin Lane April 28, 2021April 28, 2021